Figure 2.
Effect of orlistat on serum periostin level in obese nonalcoholic fatty liver disease patients.
Notes: There was no significant group difference in pretreatment serum periostin levels (P>0.05). *P<0.05, value significantly different from baseline value. **P<0.05, value significantly different between groups.